Ceruloplasmin expression by human peripheral blood lymphocytes: A new link between immunity and iron metabolism

Free Radical Biology and Medicine

Volumn 44, Issue 3, 2008, Pages 483-492

  Banha, João ^a   Marques, Liliana ^a   Oliveira, Rita ^a   Martins, Maria de Fátima ^a   Paixão, Eleonora ^a   Pereira, Dina ^b   Malhó, Rui ^c   Penque, Deborah ^a   Costa, Luciana ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b Hospital de Reynaldo dos Santos   (Portugal)

^c UNIVERSITY OF LISBON   (Portugal)

Author keywords

Ceruloplasmin; Copper; Iron; NK cells; Peripheral blood lymphocytes

Indexed keywords

CERULOPLASMIN; IRON;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE SYSTEM; IMMUNITY; IMMUNOFLUORESCENCE; IRON METABOLISM; MALE; NATURAL KILLER T CELL; NORMAL HUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

MAMMALIA; RATTUS;

EID: 38149075933     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2007.10.032     Document Type: Article

References (62)

1. Frieden E. Ceruloplasmin, a link between copper and iron metabolism. Ortop. Travmatol. Protez. 30 (1969) 87-91
2. Harris E.D. Copper transport: an overview. Proc. Soc. Exp. Biol. Med. 196 (1991) 130-140
3. Osaki S., and Johnson D.A. Mobilization of liver iron by ferroxidase (ceruloplasmin). J. Biol. Chem. 244 (1969) 5757-5758
4. Osaki S., Johnson D.A., and Frieden E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 241 (1966) 2746-2751
5. Van Eden M.E., and Aust S.D. Intact human ceruloplasmin is required for the incorporation of iron into human ferritin. Arch. Biochem. Biophys. 381 (2000) 119-126
6. Goldstein I.M., Kaplan H.B., Edelson H.S., and Weissmann G. Ceruloplasmin: ascavenger of superoxide anion radicals. J. Biol. Chem. 254 (1979) 4040-4045
7. Graf W.D., and Noetzel M.J. Radical reactions from missing ceruloplasmin: the importance of a ferroxidase as an endogenous antioxidant. Neurology 53 (1999) 446-447
8. Fox P.L., Mukhopadhyay C., and Ehrenwald E. Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin. Life Sci. 56 (1995) 1749-1758
9. Gitlin J.D. Transcriptional regulation of ceruloplasmin gene expression during inflammation. J. Biol. Chem. 263 (1988) 6281-6287
10. Moak S.A., and Greenwald R.A. Enhancement of rat serum ceruloplasmin levels by exposure to hyperoxia. Proc. Soc. Exp. Biol. Med. 177 (1984) 97-103
11. Cousins R.J. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol. Rev. 65 (1985) 238-309
12. Babu U., and Failla M.L. Copper status and function of neutrophils are reversibly depressed in marginally and severely copper-deficient rats. J. Nutr. 120 (1990) 1700-1709
13. Babu U., and Failla M.L. Respiratory burst and candidacidal activity of peritoneal macrophages are impaired in copper-deficient rats. J. Nutr. 120 (1990) 1692-1699
14. Bala S., Failla M.L., and Lunney J.K. Alterations in splenic lymphoid cell subsets and activation antigens in copper-deficient rats. J. Nutr. 121 (1991) 745-753
15. Mazumder B., Mukhopadhyay C.K., Prok A., Cathcart M.K., and Fox P.L. Induction of ceruloplasmin synthesis by IFN-gamma in human monocytic cells. J. Immunol. 159 (1997) 1938-1944
16. Ramadori G., Van Damme J., Rieder H., and Meyer zum Buschenfelde K.H. Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha. Eur. J. Immunol. 18 (1988) 1259-1264
17. Fleming R.E., Whitman I.P., and Gitlin J.D. Induction of ceruloplasmin gene expression in rat lung during inflammation and hyperoxia. Am. J. Physiol. 260 (1991) L68-L74
18. Weiss G., Wachter H., and Fuchs D. Linkage of cell-mediated immunity to iron metabolism. Immunol. Today 16 (1995) 495-500
19. De Sousa M. Lymphoid cell positioning: a new proposal for the mechanism of control of lymphoid cell migration. Symp. Soc. Exp. Biol. 32 (1978) 393-410
20. de Sousa M. Immune cell functions in iron overload. Clin. Exp. Immunol. 75 (1989) 1-6
21. de Sousa M., Porto G., Arosa F., Cardoso C., Cabeda J., Lacerda R., and Fraga J. T lymphocyte expression and function in hemochromatosis. Hemochromatosis. genetics, pathophysiol., diagnosis and treatment (2000), Cambridge University Press, Cambridge 396-407
22. Gerhard G.S., Ten Elshof A.E., and Chorney M.J. Hereditary haemochromatosis as an immunological disease. Br. J. Haematol. 100 (1998) 247-255
23. Santos M., Schilham M.W., Rademakers L.H., Marx J.J., de Sousa M., and Clevers H. Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J. Exp. Med. 184 (1996) 1975-1985
24. Feder J.N., Tsuchihashi Z., Irrinki A., Lee V.K., Mapa F.A., Morikang E., Prass C.E., Starnes S.M., Wolff R.K., Parkkila S., Sly W.S., and Schatzman R.C. The hemochromatosis founder mutation in HLA-H disrupts beta2-microglobulin interaction and cell surface expression. J. Biol. Chem. 272 (1997) 14025-14028
25. Aldred A.R., Grimes A., Schreiber G., and Mercer J.F. Rat ceruloplasmin. Molecular cloning and gene expression in liver, choroid plexus, yolk sac, placenta, and testis. J. Biol. Chem. 262 (1987) 2875-2878
26. Jaeger J.L., Shimizu N., and Gitlin J.D. Tissue-specific ceruloplasmin gene expression in the mammary gland. Biochem. J. 280 Pt 3 (1991) 671-677
27. Klomp L.W., and Gitlin J.D. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia. Hum. Mol. Genet. 5 (1996) 1989-1996
28. Patel B.N., and David S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 272 (1997) 20185-20190
29. Mittal B., Doroudchi M.M., Jeong S.Y., Patel B.N., and David S. Expression of a membrane-bound form of the ferroxidase ceruloplasmin by leptomeningeal cells. Glia 41 (2003) 337-346
30. Fortna R.R., Watson H.A., and Nyquist S.E. Glycosyl phosphatidylinositol-anchored ceruloplasmin is expressed by rat Sertoli cells and is concentrated in detergent-insoluble membrane fractions. Biol. Reprod. 61 (1999) 1042-1049
31. Yang F., Naylor S.L., Lum J.B., Cutshaw S., McCombs J.L., Naberhaus K.H., McGill J.R., Adrian G.S., Moore C.M., Barnett D.R., et al. Characterization, mapping, and expression of the human ceruloplasmin gene. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 3257-3261
32. Pan Y., Katula K., and Failla M.L. Expression of ceruloplasmin gene in human and rat lymphocytes. Biochim. Biophys. Acta 1307 (1996) 233-238
33. Bourbon M. Characterization of molecular defects in Portuguese patients with familial hypercholesterolaemia (2006), University of London, Faculty of Med., Imperial College. London
34. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. Ser. 41 (1999) 95-98
35. Camacho L., Parton R.M., Trewavas A.J., and Malhó R. [Ca2+]c distribution and oscillations in pollen tubes with confocal microscopy. A comparison of different dyes and loading methods. Protoplasma 212 (2000) 162-173
36. Platonova N.A., Vasin A.V., Klotchenko S.A., Tsymbalenko N.V., and Puchkova L.V. The revelation of expressing region in the processed ceruloplasmin gene in human genome by biocomputational and biochemical methods. Biophys. Chem. 115 (2005) 247-250
37. Daimon M., Yamatani K., Igarashi M., Fukase N., Kawanami T., Kato T., Tominaga M., and Sasaki H. Fine structure of the human ceruloplasmin gene. Biochem. Biophys. Res. Commun. 208 (1995) 1028-1035
38. Hellman N.E., Kono S., Miyajima H., and Gitlin J.D. Biochemical analysis of a missense mutation in aceruloplasminemia. J. Biol. Chem. 277 (2002) 1375-1380
39. Patel B.N., Dunn R.J., and David S. Alternative RNA splicing generates a glycosylphosphatidylinositol-anchored form of ceruloplasmin in mammalian brain. J. Biol. Chem. 275 (2000) 4305-4310
40. Hellman N.E., and Gitlin J.D. Ceruloplasmin metabolism and function. Annu. Rev. Nutr. 22 (2002) 439-458
41. Giustiniani J., Marie-Cardine A., and Bensussan A. A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity. J. Immunol. 178 (2007) 1293-1300
42. Dorner M.H., Silverstone A., Nishiya K., de Sostoa A., Munn G., and de Sousa M. Ferritin synthesis by human T lymphocytes. Science 209 (1980) 1019-1021
43. Phillips J.L. Specific binding of zinc transferrin to human lymphocytes. Biochem. Biophys. Res. Commun. 72 (1976) 634-639
44. Soltys H.D., and Brody J.I. Synthesis of transferrin by human peripheral blood lymphocytes. J. Lab. Clin. Med. 75 (1970) 250-257
45. Van Snick J.L., and Masson P.L. The binding of human lactoferrin to mouse peritoneal cells. J. Exp. Med. 144 (1976) 1568-1580
46. Stremmel W., Riedel H.D., Niederau C., and Strohmeyer G. Pathogenesis of genetic haemochromatosis. Eur. J. Clin. Investig. 23 (1993) 321-329
47. Cairo G., Conte D., Bianchi L., Fraquelli M., and Recalcati S. Reduced serum ceruloplasmin levels in hereditary haemochromatosis. Br. J. Haematol. 114 (2001) 226-229
48. Del Rey R., Froilan C., Comas C., Villanueva R., and Olveira A. Hereditary hemochromatosis associated with hypoceruloplasminemia with absence of mutations in the HFE gene. Rev. Esp. Enferm. Dig. 92 (2000) 610-611
49. Laine F., Ropert M., Lan C.L., Loreal O., Bellissant E., Jard C., Pouchard M., Le Treut A., and Brissot P. Serum ceruloplasmin and ferroxidase activity are decreased in HFE C282Y homozygote male iron-overloaded patients. J. Hepatol. 36 (2002) 60-65
50. Porto G., Cardoso C.S., Gordeuk V., Cruz E., Fraga J., Areias J., Oliveira J.C., Bravo F., Gangaidzo I.T., MacPhail A.P., Gomo Z.A., Moyo V.M., Melo G., Silva C., Justica B., and de Sousa M. Clinical and genetic heterogeneity in hereditary haemochromatosis: association between lymphocyte counts and expression of iron overload. Eur. J. Haematol. 67 (2001) 110-118
51. Cardoso E.M., Hagen K., de Sousa M., and Hultcrantz R. Hepatic damage in C282Y homozygotes relates to low numbers of CD8+ cells in the liver lobuli. Eur. J. Clin. Investig. 31 (2001) 45-53
52. Winnock M., Garcia Barcina M., Lukomska B., Huet S., Saric J., Balabaud C., and Bioulac-Sage P. Human liver-associated lymphocytes: an overview. J. Gastroenterol. Hepatol. 10 Suppl. 1 (1995) S43-S46
53. Cruz E., Lacerda R., and Porto G. NK cell number in hereditary hemochromatosis. XXVI Annual Meeting of the Portuguese Society of Immunol (2000) Porto
54. Akbar A.N., Fitzgerald-Bocarsly P.A., de Sousa M., Giardina P.J., Hilgartner M.W., and Grady R.W. Decreased natural killer activity in thalassemia major: a possible consequence of iron overload. J. Immunol. 136 (1986) 1635-1640
55. Akbar A.N., Fitzgerald-Bocarsly P.A., Giardina P.J., Hilgartner M.W., and Grady R.W. Modulation of the defective natural killer activity seen in thalassaemia major with desferrioxamine and alpha-interferon. Clin. Exp. Immunol. 70 (1987) 345-353
56. Weinberg E.D. Iron depletion: a defense against intracellular infection and neoplasia. Life Sci. 50 (1992) 1289-1297
57. Senra Varela A., Lopez Saez J.J., and Quintela Senra D. Serum ceruloplasmin as a diagnostic marker of cancer. Cancer Lett. 121 (1997) 139-145
58. Knekt P., Aromaa A., Maatela J., Rissanen A., Hakama M., Aaran R.K., Nikkari T., Hakulinen T., Peto R., and Teppo L. Serum ceruloplasmin and the risk of cancer in Finland. Br. J. Cancer 65 (1992) 292-296
59. Pousset D., Piller V., Bureaud N., and Piller F. High levels of ceruloplasmin in the serum of transgenic mice developing hepatocellular carcinoma. Eur. J. Biochem. / FEBS 268 (2001) 1491-1499
60. Itoh O., Torikai T., Satoh M., Okumura O., and Osawa T. Antitumor and toxohormone-neutralizing activities of human ceruloplasmin. Gann Gan 72 (1981) 370-376
61. Bomford A., and Williams R. Long term results of venesection therapy in idiopathic haemochromatosis. Q. J. Med. 45 (1976) 611-623
62. Klebanoff S.J. Bactericidal effect of Fe2+, ceruloplasmin, and phosphate. Arch. Biochem. Biophys. 295 (1992) 302-308